Mechanistically, IFN-γ signaling, via its receptor (IFNγR), induces STAT1 phosphorylation and inhibits the EGFR/Erk1/2 and Wnt/β-catenin signaling pathways, thereby decreasing cell proliferation in tumor epithelial cells [161]. This evidence concerns the gene IFNG and neoplasm.